MSF Press Release on Indian Court Ruling
Médecins Sans Frontières
India: Leena Menghaney + 91.98.11.36.54.12
Switzerland: Sheila Shettle + 41.79.293.0270, + 41.22.849.8403
Continue Reading
Thailand’s Compulsory Licensing Controversy
Between November 2006 and January 2007, Thailand issued compulsory licenses for two AIDS drugs (efavirnz and the combination of lopinavir+ritonavir) and one antihypertension drug (clopidegrel). The pharmaceutical industry has vehemently objected to these compulsory licenses, and has sought the US… Continue Reading
KEI Statement on IPR/Health aspects of bipartisan “New Trade Policy”
KEI statement on bipartisan trade agreement
14 May 2007
FMI: James Love james.love@keionline.org, +1.202.361.3040
On May 10, 2007, Speaker Nancy Pelosi and Ways and Means Chair Charles Rangel announced a “new bipartisan ” trade package. KEI has reviewed the details of the elements of section III of the agreement, concerning “patents, IPR and access to medicine.”
KEI Statement on Brazil Compulsory License on efavirenz
Friday, 04 May 2007 Knowledge Ecology International Statement by James Love, +1202.361.3040, "Brazil's decision to issue a compulsory license on the patents for the AIDS drug efavirenz is an important first step to implement the Doha Declaration’s requirement that the… Continue Reading
Abbott sought compulsory license in 2007 US patent dispute
(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses) On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District… Continue Reading
2007: Brazil’s latest compulsory licensing announcement
Michel Lotrowska, a musician and health activist in Brazil, posted this informative note on Brazil’s latest announcement that it was considering a compulsory license on patents for a medicine — in this case, efavirenz, the BMS/Merck AIDS drug marketed by… Continue Reading
March 8, 2007 Geneva Q&A Session on Thai White Paper
Knowledge Ecology International: Q&A Session on Thai White Paper (Facts and Evidences on the 10 Burning Issues Related to the Government Use of Patents on Three Patented Essential Drugs in Thailand) Geneva, Switzerland 8 March 2007 Thiru Balasubramaniam On Thursday,… Continue Reading
IGWG Briefing Paper on Patent Pools
Sunday, 03 June 2007
IGWG Briefing Paper on Patent Pools
Collective Management of Intellectual Property — The use of Patent Pools to expand access to essential medical technologies
KEI Research Note 2007:3 (1)
CPTech Response to 2006 PhRMA “Special 301” Submission for Chile
March 2006
CPTech Response to 2006 PhRMA “Special 301” Submission for Chile
The “Special 301” Report is a report that the office of the U.S. Trade Representative (USTR) submits annually to the House Ways and Means Committee and the Senate Finance Committee on the adequacy and effectiveness of intellectual property rights protection around the world. The report identifies those countries that the USTR consider “deny adequate and effective protection for IPR or deny fair and equitable market access for U.S. persons that rely on intellectual property protection”.